A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the leading oral semaglutide in a major clinical trial. The tablet could offer a more convenient alternative to injectable drugs like Ozempic and Wegovy because it doesn't require ref rigeration or special timing with meals. It's also cheaper to manufacture, which could expand access globally. ...read more read less